stockrow
Saturday 7 November 2026
Export FTH’s income statement to Excel — free account
Faeth Therapeutics, Inc.
- EPS
- +78.2%
- Free cash flow
- −262.7%
Quarter to September 2026, against a year earlier
21.86
1.94
+9.74%
Follow FTH
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(74.01%) | 350.35% | (195.26%) | (229.61%) | |
| (61.78%) | (151.41%) | (176.88%) | (204.67%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(121.61%) | (97.03%) | (109.16%) | (126.71%) | |
Free Cash Flow per Share |
(16.03) | (18.46) | (6.00) | (1.67) | |
Free Cash Flow |
(20.22) | (23.90) | (33.86) | (43.28) | |
Capital Expenditures |
0.23 | 0.19 | (0.01) | (0.01) | |
| Other line items | |||||
Cash ROIC |
(50.83%) | (36.49%) | (9.42%) | (12.89%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(405.24) | — | — | — | |
Operating CF/Net income |
0.97 | 0.13 | 0.17 | 0.20 | |
Depreciation/Fixed assets |
1.70 | 1.96 | 2.80 | 106.00 | |
Capex/Depreciation |
1.68 | 1.39 | (0.05) | (0.08) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(16.22) | (18.60) | (6.00) | (1.67) | |
Capex per Share |
0.19 | 0.15 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026